Gamma Knife Market
Gamma Knife market share with predicted implications of corona impact, brand share analysis, lockdown impact assessment, deep-dive competition analysis, market size and historical value analysis
Global Market Study on Gamma Knife: Asia to Witness Highest Growth by 2020
- Report code : PMRREP3742 |
- Industry : Life Sciences & Transformational Health |
- Published On : Mar-2015 |
- Pages : 102 Pages |
- Format :
Radiation therapy is a procedure entailing the precise delivery of high doses of radiation to tumors and other relevant anatomical targets. Gamma Knife radiosurgery is a major form of radiation therapy. It is mainly used to treat brain tumors, arteriovenous malformations, trigeminal neuralgia, acoustic neuroma, and pituitary tumors. In Gamma Knife surgery, specialized equipment focuses close to 200 tiny beams of radiation on a tumor or other targeted cells. These beams deliver strong doses of radiation to targeted tumor cells with refined precision. This effectively means that surrounding healthy tissues are exposed to minimal or no radiation whatsoever.
Globally, the Gamma Knife market is witnessing significant growth due to increasing prevalence of cancer and obesity and growing aging population. In addition, rising number of initiatives undertaken by various government associations and the advanced features of Gamma Knife systems are also driving the growth of the market. However, stringent regulatory requirements and prolonged approval time for Gamma Knife systems and high cost of implementation and shortage of skilled manpower inhibit the growth of the market.
The global Gamma Knife market is anticipated to grow from an estimated USD 526,733.2 thousand in 2014 to USD 651,241.9 thousand by 2020 at a CAGR of 3.6% during the forecast period.
North America is the largest region and Asia represents the fastest growing region in the Gamma Knife market. In terms of application, brain metastases represent the largest and fastest growing segment of this market.
The North American Gamma Knife market is anticipated to grow from an estimated USD 217,115.5 thousand in 2014 to USD 269,995.5 thousand by 2020 at a CAGR of 3.7% during the forecast period.
The global brain metastases are estimated at USD 360,610.2 thousand in 2014 and is expected to reach USD 448,903.1 thousand by 2020, growing at a CAGR of 3.7% during the forecast period.
Radiation therapy is a procedure entailing the precise delivery of high doses of radiation to tumors and other relevant anatomical targets. It involves the usage of sophisticated technology to ablate tumors and other abnormalities with noninvasive procedures and high doses of radiation while minimizing the exposure to surrounding healthy tissues.
Gamma Knife radiosurgery is a major form of radiation therapy. It is mainly used to treat brain tumors, arteriovenous malformations, trigeminal neuralgia, acoustic neuroma, and pituitary tumors. In Gamma Knife surgery, specialized equipment focuses close to 200 tiny beams of radiation on a tumor or other targeted cells. Each beam has minimal effect on the brain tissue and it delivers strong doses of radiation to the targeted tumor cells for treatment.
Increasing prevalence of cancer, growing aging population, rising number of initiatives undertaken by various government associations, and advanced features of Gamma Knife systems are major drivers of the global Gamma Knife market. On the other hand, stringent regulatory requirements and prolonged approval time for Gamma Knife systems as well as high cost of implementation and shortage of skilled manpower are some major concerns for the global Gamma Knife market.
In terms of geography, North America dominates the global Gamma Knife market due to increasing prevalence of cancer as well as increasing investments by radiosurgery systems manufacturing companies. In addition, increased awareness about Gamma Knife technology for cancer treatment is also boosting the growth of the Gamma Knife market in the region. The U.S. represents the largest market for Gamma Knife, followed by Canada, in North America. In Europe, Germany, France, the U.K., Italy, and Spain hold major shares of the Gamma Knife market. However, Asia represents the fastest growing region in the Gamma Knife market. This is due to increasing prevalence of cancer and growing aging population. In Latin America, rising incidence of cancer and construction of manufacturing and research facilities by many companies is driving the Gamma Knife market in the region.
This report provides in-depth analysis and estimation of the Gamma Knife market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report. The Gamma Knife market is categorized on the basis of application and geography. Based on the application, the Gamma Knife market is further categorized into brain market metastases, brain tumor, trigeminal neuralgia, arteriovenous malformations, and others. On the basis of geography, the Gamma Knife market report identify analyzes the size and predictions for North America, Europe, Asia, Latin America, and Rest of the World (RoW).
Companies covered in Gamma Knife Market Report
Some of the major players in the Gamma Knife market:
- Elekta AB.
- Varian Medical Systems, Inc.
- Huiheng Medical, Inc.
- Cyber Medical Corporation Limited.
- Masep Infini Global, Inc.
- Nordion, Inc.
- Hokai.
- ET Medical Group.
- American Shared Hospital Services.
These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.
